News
Shares of Novo Nordisk ( NVO 4.81%), the Danish pharmaceuticals company famed for Ozempic and Wegovy weight loss drugs, ...
Contract bookings -- $1.7 million in contracts signed for fiscal Q3 2025, adding $600,000 in ARR for fiscal 2025; year to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback